Finance

Lists
Why is SMMT up 4.71%?
Dive Deeper
SMMT:NASDAQ
Summit Therapeutics Inc
$18.12
+4.71%
(+0.82) 1D
Oct 7, 1:06:57 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMMT...
Open
$17.10
High
$18.33
Low
$16.98
Mkt. cap
13.10B
Avg. vol.
7.17M
Volume
5.16M
52-wk high
$29.23
52-wk low
$12.07
EPS
-$1.12
Beta
-1.51
Shares outstanding
797.75M
No. of employees
61
Open
$17.10
High
$18.33
Low
$16.98
Mkt. cap
13.10B
Avg. vol.
7.17M
Volume
5.16M
52-wk high
$29.23
52-wk low
$12.07
EPS
-$1.12
Beta
-1.51
Shares outstanding
797.75M
No. of employees
61
News stories
From web sources and news partners
About Summit Therapeutics Inc
CEO-
Employees61
FoundedAug 4, 2004
Headquarters-
Sector-
Website-
Analyst ratings
Based on 16 analysts giving stock ratings to SMMT in the past 3 months
Buy
Buy
10
Hold
6
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for SMMT in the last 3 months.
Highest
Current $18.12
$43.00 (+137.24%)
Average
$28.26 (+55.92%)
Lowest
$11.90 (-34.34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Hold
Maintained
$20.00
+10.3%
10/01/2026
Faisal Khurshid
Jefferies
Buy
Maintained
-
-
09/29/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
-
-
09/30/2026
Dara Azar
Stifel Nicolaus
Buy
Maintained
-
-
09/29/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$34.00
+87.6%
09/29/2026
Unknown Analyst
Leerink Partners
Hold
Reiterated
$13.00
-28.3%
09/29/2026
Kelsey Goodwin
Piper Sandler
Hold
Maintained
$16.00
-11.7%
09/29/2026
David Dai
UBS
Buy
Maintained
$33.00
+82.1%
09/28/2026
Mohit Bansal
Wells Fargo
Buy
Maintained
$30.00
+65.5%
09/28/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$43.00
+137.2%
09/30/2026
Jeffrey Walch
Bernstein
Hold
Maintained
$11.90
-34.3%
09/25/2026
Salveen Richter
Goldman Sachs
Buy
Maintained
$41.00
+126.2%
09/13/2026
Mara Goldstein
Clear Street
Buy
Reiterated
$31.00
+71%
09/03/2026
Kalpit Patel
Wolfe Research
Hold
Maintained
-
-
08/16/2026
Unknown Analyst
Clear Street
Buy
Maintained
$31.00
+71%
08/03/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
07/27/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$38.00
+109.7%
07/23/2026
Unknown Analyst
Bernstein
Sell
Initiated
$7.70
-57.5%
05/21/2026
William Maughan
Clear Street
Buy
Maintained
$31.00
+71%
05/01/2026
Stephen Willey
Stifel Nicolaus
Buy
Initiated
$45.00
+148.3%
04/08/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
$35.00
+93.1%
02/24/2026
Previous reports
Loading Previous Earnings...
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps